Application 212669

Type
ANDA
Sponsor
CELLTRION

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DEFERASIROXDEFERASIROXTABLET;ORAL90MGNoNo
002DEFERASIROXDEFERASIROXTABLET;ORAL180MGNoNo
003DEFERASIROXDEFERASIROXTABLET;ORAL360MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
72606-013DeferasiroxDeferasiroxCELLTRION USA, INC.ANDACurrent
72606-014DeferasiroxDeferasiroxCELLTRION USA, INC.ANDACurrent
72606-015DeferasiroxDeferasiroxCELLTRION USA, INC.ANDACurrent